0001213900-22-028976.txt : 20220523
0001213900-22-028976.hdr.sgml : 20220523
20220523163203
ACCESSION NUMBER: 0001213900-22-028976
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220519
FILED AS OF DATE: 20220523
DATE AS OF CHANGE: 20220523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gold Lawrence Marshall
CENTRAL INDEX KEY: 0001355868
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 22952158
MAIL ADDRESS:
STREET 1: 830 MENLO AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER NAME:
FORMER CONFORMED NAME: GOLD LAWRENCE
DATE OF NAME CHANGE: 20060310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 MENLO AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-507-0669
MAIL ADDRESS:
STREET 1: 830 MENLO AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4
1
ownership.xml
X0306
4
2022-05-19
0
0001690080
180 Life Sciences Corp.
ATNF
0001355868
Gold Lawrence Marshall
3000 EL CAMINO REAL, BLDG. 4,
SUITE 200
PALO ALTO
CA
94306
1
0
0
0
Common Stock
2022-05-19
4
A
0
10570
1.36
A
22028
D
Non-Qualified Stock Option (right to buy)
1.36
2022-05-19
4
A
0
15000
0.0
A
2032-05-19
Common Stock
15000
15000
D
Issued in consideration for serving on the Board of Directors, as a Member of the Audit and Compensation Committee of the Board of Directors, and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarter ended March 31, 2022. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the following 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.
/s/ Larry Gold
2022-05-23